Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Jan 21, 2023; 29(3): 536-548
Published online Jan 21, 2023. doi: 10.3748/wjg.v29.i3.536
Table 3 Comparison between the training set and the testing set
Testing set
Training set
P value

n = 68
n = 260
Sex, n (%)0.543
Male45 (66.2)182 (70.0)
Female23 (33.8)78 (30.0)
Age (yr), median (quartile)63 (57-71)63 (55-68)0.322
BMI (Kg/m2), median (quartile)23.7 (22.0-25.0)22.9 (21.3-25.1)0.248
Diabetes mellitus, n (%)0.303
Yes6 (8.8)35 (13.5)
No62 (91.2)225 (86.5)
Albumin (g/L), median (quartile)39 (36-41)40 (37-42)0.111
CEA (ng/mL), n (%)(Missing=5)0.863
> 521 (30.9)76 (29.8)
≤ 547 (69.1)179 (70.2)
nCRT, n (%)0.081
Yes12 (17.6)73 (28.1)
No56 (82.4)187 (71.9)
Distance from anus (cm), median (quartile)7.1 (5.8-8.7)7.0 (5.6-8.7)0.828
CRM evaluated by MRI, n (%)0.051
Positive9 (13.2)63 (24.2)
Negative59 (86.8)197 (75.8)
Tumor size (cm), n (%)0.340
≥ 56 (8.8)34 (13.1)
< 562 (91.2)226 (86.9)
Number of linear stapler cartridges, n (%)0.470
≥ 310 (14.7)48 (18.5)
≤ 258 (85.3)212 (81.5)
Length of cartridges used, n (%)0.603
Only 60 mm62 (91.2)242 (93.1)
45 mm ± 60 mm6 (8.8)18 (6.9)
Anastomotic leakage, n (%)0.686
Yes11 (16.2)37 (14.2)
No57 (83.8)223 (85.8)